Share with others who have ER-/PR-/HER2- breast cancer.
Posted on: May 20, 2020 05:13PM
Keytruda Plus Chemotherapy Offers More Benefits Than Chemo Alone as First Treatment for Metastatic Triple-Negative Breast Cancer With High Levels of PD-L1
May 14, 2020
Keytruda plus chemotherapy offered better progression-free survival than chemotherapy alone as the first treatment for metastatic triple-negative breast cancer or triple-negative breast cancer that has come back in the breast area but can't be removed with surgery, with high levels of the PD-L1 protein. Read more...